State of Alaska Department of Revenue’s Pacira BioSciences PCRX Stock Holding History

State of Alaska Department of Revenue’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$687K	Sell	27,144 -7,331	-21%	-$173K	0.01%	1266
2026 Q1	$778K	Sell	34,475 -1,650	-5%	-$36.7K	0.01%	1202
2025 Q4	$933K	Buy	36,125 +10,807	+43%	+$257K	0.01%	1118
2025 Q3	$651K	Sell	25,318 -2,243	-8%	-$55.1K	0.01%	1307
2025 Q2	$658K	Buy	27,561 +1,977	+8%	+$49.8K	0.01%	1256
2025 Q1	$635K	Sell	25,584 -583	-2%	-$14K	0.01%	1255
2024 Q4	$492K	Sell	26,167 -156	-0.6%	-$2.74K	0.01%	1391
2024 Q3	$396K	Sell	26,323 -1,005	-4%	-$17.2K	﹤0.01%	1483
2024 Q2	$781K	Sell	27,328 -962	-3%	-$27.4K	0.01%	1145
2024 Q1	$826K	Sell	28,290 -279	-1%	-$8.57K	0.01%	1135
2023 Q4	$963K	Sell	28,569 -348	-1%	-$10.2K	0.01%	1024
2023 Q3	$887K	Sell	28,917 -1,343	-4%	-$48.4K	0.01%	1009
2023 Q2	$1.21M	Sell	30,260 -1,159	-4%	-$47.9K	0.01%	879
2023 Q1	$1.28M	Sell	31,419 -521	-2%	-$20.7K	0.02%	851
2022 Q4	$1.23M	Buy	31,940 +215	+0.7%	+$10.5K	0.02%	851
2022 Q3	$1.69M	Sell	31,725 -2,637	-8%	-$147K	0.02%	686
2022 Q2	$2M	Buy	34,362 +3,290	+11%	+$216K	0.02%	643
2022 Q1	$2.37M	Sell	31,072 -470	-1%	-$31.3K	0.03%	603
2021 Q4	$1.9M	Sell	31,542 -885	-3%	-$48.8K	0.02%	741
2021 Q3	$1.81M	Buy	32,427 +1,965	+6%	+$113K	0.02%	759
2021 Q2	$1.85M	Buy	30,462 +772	+3%	+$48.9K	0.02%	736
2021 Q1	$2.08M	Sell	29,690 -4,120	-12%	-$294K	0.02%	644
2020 Q4	$2.02M	Sell	33,810 -5,927	-15%	-$347K	0.02%	606
2020 Q3	$2.39M	Buy	39,737 +10	+0%	+$581	0.03%	492
2020 Q2	$2.08M	Buy	39,727 +3,010	+8%	+$126K	0.03%	565
2020 Q1	$1.23M	Buy	36,717 +5,205	+17%	+$216K	0.02%	675
2019 Q4	$1.43M	Buy	31,512 +812	+3%	+$34.5K	0.02%	714
2019 Q3	$1.17M	Buy	+30,700	New	+$1.23M	0.02%	774

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

State of Alaska Department of Revenue's PCRX Position: Q2 2026 in Review

State of Alaska Department of Revenue reduced its Pacira BioSciences (PCRX) stake by 21% in Q2 2026, selling an estimated $173K and leaving 27,144 shares worth $687K. The position accounts for 0.01% of the portfolio, ranked #1266.

State of Alaska Department of Revenue first reported a position in PCRX in Q3 2019 and has held it in 28 quarters since. The position peaked at $2.39M in Q3 2020. 146 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

State of Alaska Department of Revenue held 27,144 shares of Pacira BioSciences worth $687K as of Q2 2026.
State of Alaska Department of Revenue sold 7,331 Pacira BioSciences shares in Q2 2026, an estimated $173K.
Pacira BioSciences made up 0.01% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #1266 holding.
State of Alaska Department of Revenue first reported a position in Pacira BioSciences in Q3 2019 and has held it in 28 quarters since.
State of Alaska Department of Revenue's Pacira BioSciences position peaked at $2.39M in Q3 2020.
146 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.